---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-000294"
form_type: "8-K"
ticker: "GTHP"
cik: "0000924515"
company_name: "GUIDED THERAPEUTICS INC"
filed_at: "2022-01-07T23:59:59+00:00"
generated_at: "2026-06-27T20:02:17.774885+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Guided Therapeutics approves 1-for-20 reverse stock split; FINRA effective date pending

## Summary
- Board approved 1-for-20 reverse split on Dec 30, 2021; Certificate of Amendment filed with Delaware.
- Each 20 shares reclassified into 1 share; no fractional shares issued, whole share granted instead.
- Options, warrants, and convertible securities adjusted proportionally to reflect the split.
- Stockholder approval obtained in July 2021; FINRA has not yet declared effective date.

## SEC filing metadata
- accession: 0001654954-22-000294
- form_type: 8-K
- ticker: GTHP
- cik: 0000924515
- company_name: GUIDED THERAPEUTICS INC
- filed_at: 2022-01-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/924515/000165495422000294/0001654954-22-000294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/924515/000165495422000294/gthp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-000294
- JSON: https://secwatch.observer/filing/0001654954-22-000294.json
- Plain text: https://secwatch.observer/filing/0001654954-22-000294.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.